In vitro activity of lomefloxacin (SC 47111 or NY-198) against Chlamydia trachomatis strains.
The in vitro activity of lomefloxacin (SC 47111 or NY-198), a new quinolone antibiotic, against 11 strains of Chlamydia trachomatis was determined and compared to doxycycline, norfloxacin, and ciprofloxacin. Lomefloxacin had anti-chlamydial activity comparable to that of ciprofloxacin. (MIC and MBC90, 2 micrograms/ml).